Detalhe da pesquisa
1.
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients.
Br J Cancer
; 121(7): 584-592, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31434988
2.
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition.
Proc Natl Acad Sci U S A
; 113(43): 12238-12243, 2016 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27791010
3.
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis.
BMC Cancer
; 17(1): 366, 2017 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28545541
4.
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues.
J Cell Mol Med
; 20(12): 2341-2348, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27419385
5.
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.
Proc Natl Acad Sci U S A
; 110(8): 2916-21, 2013 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23359684
6.
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis.
J Transl Med
; 11: 162, 2013 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23819652
7.
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis.
Clin Chem Lab Med
; 51(9): 1815-24, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24013103
8.
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome.
Clin Chem Lab Med
; 50(12): 2189-98, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23096757
9.
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma.
BMC Clin Pathol
; 12: 22, 2012 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23151048
10.
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence.
BMC Cancer
; 9: 253, 2009 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-19635143
11.
Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas.
Am J Obstet Gynecol
; 201(1): 70.e1-9, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19426958
12.
Human kallikrein 5: an interesting novel biomarker in ovarian cancer patients that elicits humoral response.
Int J Gynecol Cancer
; 19(6): 1015-21, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19820362
13.
Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes.
Am J Obstet Gynecol
; 196(3): 245.e1-11, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17346539
14.
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
J Exp Clin Cancer Res
; 36(1): 63, 2017 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28482906
15.
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines.
Oncol Lett
; 12(4): 2493-2500, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27698818
16.
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery.
Oncotarget
; 6(33): 34617-28, 2015 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26416446
17.
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues.
PLoS One
; 9(12): e113781, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25473950
18.
HE4 and epithelial ovarian cancer: comparison and clinical evaluation of two immunoassays and a combination algorithm.
Clin Chim Acta
; 412(15-16): 1447-53, 2011 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21557935
19.
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management.
Cancer Epidemiol Biomarkers Prev
; 20(12): 2496-506, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22028406
20.
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor.
Clin Exp Metastasis
; 28(7): 689-700, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21725665